Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

PHR

Phreesia Inc

Jan 17 • 04:00PM ET

27.21

Dollar change +0.41
Percentage change 1.53	%

Healthcare • Health Information Services • USA • NYSE

Peers: VEEV UNH TDOC EVH GEHC ADP MASI BLKB HIMS HSTM

| Held by: VTI IWM VXF VB IWO VBK SCHA VTWO FESM VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.47	Insider Own	7.44%	Shs Outstand	58.08M	Perf Week	1.99%
Market Cap	1.58B	Forward P/E	-	EPS next Y	-0.29	Insider Trans	-4.88%	Shs Float	53.80M	Perf Month	6.12%
Income	-82.78M	PEG	-	EPS next Q	-0.18	Inst Own	95.76%	Short Float	5.25%	Perf Quarter	30.50%
Sales	405.14M	P/S	3.90	EPS this Y	56.68%	Inst Trans	2.24%	Short Ratio	6.64	Perf Half Y	20.13%
Book/sh	4.38	P/B	6.21	EPS next Y	73.29%	ROA	-22.07%	Short Interest	2.82M	Perf Year	13.23%
Cash/sh	1.41	P/C	19.35	EPS next 5Y	-	ROE	-31.89%	52W Range	17.07 - 29.16	Perf YTD	8.15%
Dividend Est.	-	P/FCF	332.26	EPS past 5Y	-15.39%	ROI	-31.15%	52W High	-6.67%	Beta	0.96
Dividend TTM	-	Quick Ratio	1.73	Sales past 5Y	29.21%	Gross Margin	59.43%	52W Low	59.40%	ATR (14)	1.18
Dividend Ex-Date	-	Current Ratio	1.73	EPS Y/Y TTM	45.17%	Oper. Margin	-19.76%	RSI (14)	62.18	Volatility	3.36% 4.76%
Employees	1438	Debt/Eq	0.08	Sales Y/Y TTM	19.91%	Profit Margin	-20.43%	Recom	1.13	Target Price	31.50
Option/Short	Yes / Yes	LT Debt/Eq	0.04	EPS Q/Q	56.96%	Payout	-	Rel Volume	0.73	Prev Close	26.80
Sales Surprise	0.45%	EPS Surprise	-5.71%	Sales Q/Q	16.57%	Earnings	Dec 09 AMC	Avg Volume	425.77K	Price	27.21
SMA20	4.69%	SMA50	17.33%	SMA200	21.44%	Trades		Volume	309,924	Change	1.53%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$24 → $32
Feb-26-24	Initiated	Truist	Buy	$35
Jan-17-24	Upgrade	DA Davidson	Neutral → Buy	$30 → $32
Jan-03-24	Initiated	Barclays	Overweight	$29
Apr-12-23	Initiated	Stephens	Overweight	$37
Jan-04-23	Reiterated	Needham	Buy	$35 → $40
Dec-13-22	Upgrade	Citigroup	Neutral → Buy	$40
Dec-09-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$31 → $34
Oct-13-22	Initiated	DA Davidson	Neutral	$25
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight	$40
Apr-14-22	Initiated	Guggenheim	Buy	$45
Jan-06-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$57 → $41
Dec-02-21	Initiated	Jefferies	Buy	$70
Sep-02-21	Reiterated	Needham	Buy	$70 → $81
Aug-27-21	Initiated	Canaccord Genuity	Buy	$81
Jul-13-21	Initiated	JMP Securities	Mkt Outperform	$80
Jun-08-21	Initiated	Berenberg	Buy	$70
Apr-29-21	Resumed	JP Morgan	Overweight	$64
Apr-01-21	Initiated	Robert W. Baird	Outperform	$60
Nov-11-20	Initiated	Stephens	Overweight	$50

Show Previous Ratings

Jan-14-25 12:00PM	Phreesia (PHR) Upgraded to Buy: Here's Why (Zacks)
Jan-08-25 09:55AM	Should You Buy Phreesia (PHR) After Golden Cross? (Zacks) +5.37%
Dec-20-24 09:55AM	Wall Street Analysts See a 25% Upside in Phreesia (PHR): Can the Stock Really Move This High? (Zacks) +5.54%
Dec-12-24 07:17AM	Phreesia price target lowered to $30 from $34 at Baird (TipRanks)
Dec-10-24 08:13AM	Q3 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) +11.60%
02:01AM	Loading…
02:01AM	Phreesia Inc (PHR) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow (GuruFocus.com)
Dec-09-24 06:00PM	Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:20PM	Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:21PM	Phreesia: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Phreesia Announces Third Quarter Fiscal 2025 Results (Business Wire)
Dec-06-24 09:15AM	Curious about Phreesia (PHR) Q3 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Nov-22-24 06:48AM	Phreesia Named to The Software Reports Top 100 Software Companies for the Third Consecutive Year (Business Wire)
Nov-07-24 04:26AM	Phreesia (PHR) Moves 13.9% Higher: Will This Strength Last? (Zacks)
Nov-01-24 06:48AM	Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results (Business Wire)
Oct-28-24 06:48AM	Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration (Business Wire)
12:14PM	Loading…
Oct-11-24 12:14PM	Is Phreesia, Inc. (NYSE:PHR) The Top Stock With Improving Technical Ratings According To Piper Sandler? (Insider Monkey)
Oct-10-24 09:35AM	Down -10.25% in 4 Weeks, Here's Why Phreesia (PHR) Looks Ripe for a Turnaround (Zacks)
Oct-08-24 06:48AM	Phreesia Joins the Network Advertising Initiative as a Member, Demonstrating Ongoing Commitment to Industry-Leading Privacy Practices (Business Wire)
Oct-03-24 06:48AM	Phreesia and Ad Council Partnership Yields High Patient Engagement in 3 Mental Health Awareness Campaigns (Business Wire)
Oct-01-24 06:48AM	Phreesia Secures New Contract With CMS as Report Shows Gains in Patient Activation in First Year of Kidney Care Choices (KCC) Model (Business Wire)
Sep-19-24 06:48AM	New Research Shows Point-of-Care Patient Outreach Supports Vaccine Confidence and Adoption (Business Wire)
Sep-17-24 04:28PM	CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence (Business Wire)
Sep-05-24 12:39PM	Q2 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) +6.29%
Sep-04-24 06:00PM	Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:15PM	Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:15PM	Phreesia: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Second Quarter Fiscal 2025 Results (Business Wire)
Sep-03-24 09:03AM	Earnings To Watch: Phreesia Inc (PHR) Reports Q2 2025 Result (GuruFocus.com) -7.43%
Aug-29-24 09:15AM	Phreesia (PHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
06:48AM	Phreesia and American Academy of Pediatrics Join in Campaign to Increase Childhood MMR Vaccination (Business Wire)
06:48AM	Loading…
Aug-08-24 06:48AM	Bob Glazer Joins Phreesia as Strategic Advisor (Business Wire)
Aug-05-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Salesforce, and Phreesia and Encourages Investors to Contact the Firm (GlobeNewswire)
Aug-01-24 06:48AM	Phreesia Sets Release Date for Fiscal Second Quarter 2025 Results (Business Wire)
Jul-30-24 06:48AM	Phreesia Now Available on Oracle Healthcare Marketplace (Business Wire)
Jul-19-24 09:55AM	Wall Street Analysts Think Phreesia (PHR) Could Surge 27.77%: Read This Before Placing a Bet (Zacks)
Jul-12-24 12:00PM	Phreesia (PHR) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jun-10-24 10:26AM	New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease (Business Wire)
Jun-04-24 09:35AM	Here's Why Phreesia (PHR) is Poised for a Turnaround After Losing -18.25% in 4 Weeks (Zacks)
May-31-24 11:59AM	Q1 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) -11.22%
May-30-24 08:54PM	PHR Stock Earnings: Phreesia Beats EPS, Beats Revenue for Q1 2025 (InvestorPlace)
05:30PM	Compared to Estimates, Phreesia (PHR) Q1 Earnings: A Look at Key Metrics (Zacks)
05:15PM	Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:08PM	Phreesia: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces First Quarter Fiscal 2025 Results (Business Wire)
May-28-24 06:48AM	Phreesia Joins the MEDITECH Alliance Program as an Innovator Partner (Business Wire)
May-24-24 09:15AM	Unlocking Q1 Potential of Phreesia (PHR): Exploring Wall Street Estimates for Key Metrics (Zacks)
May-23-24 04:30PM	Phreesias Amy Patel Named One of PM360s 2024 ELITE 100 (Business Wire)
May-21-24 04:30PM	Phreesia Named as One of Modern Healthcares Best Places to Work in Healthcare for the Eighth Time (Business Wire)
May-01-24 06:46AM	Phreesias Alicia Cowley and Natasha Vega Named to MM+Ms Women to Watch for 2024 (Business Wire)
Apr-29-24 06:48AM	Phreesia Sets Release Date for Fiscal First Quarter 2025 Results (Business Wire)
Mar-25-24 07:01PM	Insider Sell: COO Evan Roberts Sells 25,962 Shares of Phreesia Inc (PHR) (GuruFocus.com)
Mar-19-24 06:48AM	Phreesia Announces Jack Callahan as New Chief Technology Officer (Business Wire)
Mar-17-24 10:22AM	Phreesia, Inc. (NYSE:PHR) Q4 2024 Earnings Call Transcript (Insider Monkey)
Mar-15-24 06:56AM	Q4 2024 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-24 08:55PM	PHR Stock Earnings: Phreesia Misses EPS, Beats Revenue for Q4 2024 (InvestorPlace)
06:00PM	Phreesia (PHR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:22PM	Phreesia: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Fourth Quarter Fiscal 2024 Results (Business Wire)
Mar-07-24 10:00AM	Will Phreesia (PHR) Report Negative Earnings Next Week? What You Should Know (Zacks)
Feb-27-24 04:05PM	Phreesias Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium (Business Wire)
Feb-20-24 06:48AM	New Data Shows That Engaging Patients with Relevant Cancer-Prevention Information During Check-In Increases Screening Rates (Business Wire) -6.32%
Feb-19-24 11:53AM	Phreesia (PHR) Rose on 2024 Guidance (Insider Monkey)
Feb-05-24 04:05PM	Phreesia Sets Release Date for Fiscal Fourth Quarter 2024 Results (Business Wire)
06:54AM	Bull Of The Day: Phreesia (PHR) (Zacks)
Jan-23-24 06:40AM	Phreesia Joins Call to Action to Improve Adult Vaccination Rates (Business Wire)
Jan-18-24 07:59PM	Phreesia Inc CFO Balaji Gandhi Sells 10,124 Shares (GuruFocus.com)
Jan-16-24 04:05PM	Phreesias Audrey Gato Named as a Top Woman Leader in SaaS (Business Wire)
Jan-11-24 06:44AM	Phreesias Post-Script Engagement named one of PM360s 2023 Most Innovative Technologies (Business Wire)
Dec-27-23 09:55AM	Does Phreesia (PHR) Have the Potential to Rally 30.09% as Wall Street Analysts Expect? (Zacks)
08:06AM	What Caused a -40% Drop in Phreesia (PHR) Shares? (Insider Monkey)
Dec-11-23 09:55AM	Wall Street Analysts Predict a 77.77% Upside in Phreesia (PHR): Here's What You Should Know (Zacks)
Dec-08-23 08:21AM	Phreesia, Inc. (NYSE:PHR) Q3 2024 Earnings Call Transcript (Insider Monkey)
Dec-06-23 10:37AM	Q3 2024 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) +21.22%
Dec-05-23 06:00PM	Here's What Key Metrics Tell Us About Phreesia (PHR) Q3 Earnings (Zacks)
05:40PM	Phreesia Inc (PHR) Reports Revenue Growth and Narrowed Net Loss in Q3 Fiscal 2024 (GuruFocus.com)
05:15PM	Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:17PM	Phreesia: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Third Quarter Fiscal 2024 Results (Business Wire)
Dec-01-23 06:00AM	CMS Includes the Patient Activation Measure in its Merit-Based Incentive Payment System Starting in 2024 (Business Wire)
Nov-16-23 03:12AM	Here's Why Phreesia (PHR) Declined in Q3 (Insider Monkey)
Nov-08-23 06:00AM	Phreesia Achieves HITRUST Risk-Based, 2-Year Certification Demonstrating the Highest Level of Information Protection Assurance (Business Wire)
Nov-01-23 09:12AM	Phreesia (PHR) Surges 10.3%: Is This an Indication of Further Gains? (Zacks)
06:03AM	Phreesia Sets Release Date for Fiscal Third Quarter 2024 Results (Business Wire)
Sep-15-23 10:01PM	Insider Sell: Evan Roberts Sells 3,907 Shares of Phreesia Inc (PHR) (GuruFocus.com)
Sep-14-23 09:39PM	Principal Accounting Officer Janet Gunzburg Sells 934 Shares of Phreesia Inc (GuruFocus.com)
Sep-11-23 12:11PM	Phreesia Inc (PHR): A Deep Dive into Its Performance Potential (GuruFocus.com)
Sep-07-23 12:08PM	Phreesia Inc (PHR): A Deep Dive into Its Performance Potential (GuruFocus.com) -22.11%
11:45AM	Is Phreesia (PHR) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
09:30AM	Compared to Estimates, Phreesia (PHR) Q2 Earnings: A Look at Key Metrics (Zacks)
09:00AM	Phreesia, Inc. (NYSE:PHR) Q2 2024 Earnings Call Transcript (Insider Monkey)
07:37AM	Q2 2024 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents)
Sep-06-23 05:15PM	Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:07PM	Phreesia: Fiscal Q2 Earnings Snapshot (AP Finance)
04:03PM	Phreesia Announces Second Quarter Fiscal 2024 Results (Business Wire)
Sep-04-23 12:00PM	All You Need to Know About Phreesia (PHR) Rating Upgrade to Buy (Zacks)
09:55AM	How Much Upside is Left in Phreesia (PHR)? Wall Street Analysts Think 27.26% (Zacks)
08:39AM	Nextgen Healthcare (NXGN) Surges 6.2%: Is This an Indication of Further Gains? (Zacks)
Aug-31-23 08:40AM	Should You Buy and Phreesia (PHR) Ahead of Earnings? (Zacks)
Aug-16-23 12:58PM	Phreesia Named to The Software Reports "Top 100 Software Companies" for the Second Consecutive Year (Business Wire)

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hoffman Allison C	General Counsel & Secretary	Jan 15 '25	Sale	26.90	4,585	123,320	154,552	Jan 17 06:10 PM
Indig Chaim	Chief Executive Officer	Jan 15 '25	Sale	26.98	2,990	80,674	1,259,230	Jan 17 06:08 PM
VanDuyn Amy Beth	SVP, Human Resources	Jan 15 '25	Sale	26.98	604	16,297	115,029	Jan 17 06:06 PM
Hui Yvonne	Principal Accounting Officer	Jan 15 '25	Sale	26.87	381	10,237	25,774	Jan 17 06:05 PM
Linetsky David	SVP, Life Sciences	Jan 15 '25	Sale	26.98	1,946	52,506	237,265	Jan 17 06:03 PM
Roberts Evan	Chief Operating Officer	Jan 15 '25	Sale	26.98	1,785	48,162	768,208	Jan 17 06:02 PM
Gandhi Balaji	Chief Financial Officer	Jan 15 '25	Sale	26.98	836	22,556	147,673	Jan 17 06:00 PM
Hui Yvonne	Principal Accounting Officer	Jan 14 '25	Sale	26.38	362	9,548	26,155	Jan 16 04:14 PM
Hui Yvonne	Officer	Jan 15 '25	Proposed Sale	26.87	381	10,237		Jan 15 04:03 PM
Linetsky David	Officer	Jan 15 '25	Proposed Sale	26.98	1,946	52,506		Jan 15 03:27 PM
VanDuyn Amy Beth	Officer	Jan 15 '25	Proposed Sale	26.98	604	16,297		Jan 15 03:17 PM
Indig Chaim	Officer	Jan 15 '25	Proposed Sale	26.98	2,990	80,674		Jan 15 03:16 PM
Roberts Evan	Officer	Jan 15 '25	Proposed Sale	26.98	1,785	48,162		Jan 15 03:15 PM
Gandhi Balaji	Officer	Jan 15 '25	Proposed Sale	26.98	836	22,556		Jan 15 03:12 PM
Hoffman Allison C	Officer	Jan 15 '25	Proposed Sale	26.98	1,089	29,383		Jan 15 03:08 PM
Hoffman Allison C	Officer	Jan 15 '25	Proposed Sale	26.87	3,496	93,938		Jan 15 10:59 AM
Hui Yvonne	Officer	Jan 14 '25	Proposed Sale	26.38	362	9,548		Jan 14 03:16 PM
Hui Yvonne	Principal Accounting Officer	Jan 10 '25	Sale	27.85	388	10,806	26,517	Jan 13 05:50 PM
Roberts Evan	Chief Operating Officer	Jan 08 '25	Sale	27.95	2,681	74,940	769,993	Jan 10 04:30 PM
Hui Yvonne	Principal Accounting Officer	Jan 08 '25	Sale	28.00	288	8,064	26,905	Jan 10 04:28 PM
Hui Yvonne	Officer	Jan 10 '25	Proposed Sale	27.85	388	10,806		Jan 10 10:40 AM
Roberts Evan	Chief Operating Officer	Jan 07 '25	Sale	27.00	7,319	197,613	772,674	Jan 08 05:28 PM
Roberts Evan	Chief Operating Officer	Jan 06 '25	Sale	26.61	2,873	76,438	779,993	Jan 08 05:28 PM
Gandhi Balaji	Chief Financial Officer	Jan 06 '25	Sale	26.61	3,195	85,005	148,509	Jan 08 05:26 PM
VanDuyn Amy Beth	SVP, Human Resources	Jan 06 '25	Sale	26.61	1,311	34,880	115,633	Jan 08 05:24 PM
Indig Chaim	Chief Executive Officer	Jan 06 '25	Sale	26.61	5,375	143,005	1,262,220	Jan 08 05:23 PM
Hoffman Allison C	General Counsel & Secretary	Jan 06 '25	Sale	26.61	3,982	105,943	159,137	Jan 08 05:22 PM
Linetsky David	SVP, Life Sciences	Jan 06 '25	Sale	26.61	3,133	83,355	239,211	Jan 08 05:21 PM
Roberts Evan	Officer	Jan 08 '25	Proposed Sale	27.95	2,681	74,940		Jan 08 04:12 PM
Hui Yvonne	Officer	Jan 08 '25	Proposed Sale	28.00	288	8,064		Jan 08 10:58 AM
Roberts Evan	Officer	Jan 07 '25	Proposed Sale	27.00	7,319	197,613		Jan 07 04:18 PM
Linetsky David	Officer	Jan 06 '25	Proposed Sale	26.61	3,133	83,355		Jan 06 04:19 PM
Indig Chaim	Officer	Jan 06 '25	Proposed Sale	26.61	5,375	143,005		Jan 06 04:18 PM
Roberts Evan	Officer	Jan 06 '25	Proposed Sale	26.61	2,873	76,438		Jan 06 04:15 PM
VanDuyn Amy Beth	Officer	Jan 06 '25	Proposed Sale	26.61	1,311	34,880		Jan 06 04:05 PM
Gandhi Balaji	Officer	Jan 06 '25	Proposed Sale	26.61	3,195	85,005		Jan 06 03:56 PM
Hoffman Allison C	Officer	Jan 06 '25	Proposed Sale	26.61	3,982	105,943		Jan 06 03:56 PM
Hoffman Allison C	General Counsel & Secretary	Dec 18 '24	Sale	24.88	3,495	86,956	116,296	Dec 19 06:01 PM
Linetsky David	SVP, Life Sciences	Dec 18 '24	Sale	25.38	24	609	8,851	Dec 19 05:59 PM
Linetsky David	SVP, Life Sciences	Dec 17 '24	Sale	25.06	61	1,529	8,875	Dec 18 08:30 PM
Linetsky David	SVP, Life Sciences	Dec 16 '24	Sale	24.88	35	871	8,936	Dec 18 08:30 PM
Linetsky David	Member of immediate family of	Dec 18 '24	Proposed Sale	25.38	24	609		Dec 18 03:27 PM
Hoffman Allison C	Officer	Dec 18 '24	Proposed Sale	24.88	3,495	86,956		Dec 18 10:25 AM
Weintraub Michael	Director	Dec 13 '24	Option Exercise	4.71	20,565	96,861	263,392	Dec 17 05:14 PM
Weintraub Michael	Director	Dec 16 '24	Option Exercise	4.71	861	4,055	243,688	Dec 17 05:14 PM
Weintraub Michael	Director	Dec 13 '24	Sale	25.04	20,565	515,038	242,827	Dec 17 05:14 PM
Weintraub Michael	Director	Dec 16 '24	Sale	25.26	861	21,752	242,827	Dec 17 05:14 PM
Linetsky David	Member of immediate family of	Dec 17 '24	Proposed Sale	25.06	61	1,529		Dec 17 03:40 PM
Weintraub Michael	Director	Dec 16 '24	Proposed Sale	25.26	861	21,752		Dec 16 05:23 PM
Linetsky David	Member of immediate family of	Dec 16 '24	Proposed Sale	24.88	35	871		Dec 16 03:22 PM
Weintraub Michael	Director	Dec 11 '24	Option Exercise	4.71	18,574	87,484	261,401	Dec 13 04:16 PM
Weintraub Michael	Director	Dec 11 '24	Sale	25.10	18,574	466,191	242,827	Dec 13 04:16 PM
Weintraub Michael	Director	Dec 13 '24	Proposed Sale	25.04	20,565	515,038		Dec 13 04:15 PM
Linetsky David	SVP, Life Sciences	Dec 11 '24	Sale	24.85	11,853	294,559	188,354	Dec 13 04:13 PM
Roberts Evan	Chief Operating Officer	Dec 10 '24	Sale	24.09	25,000	602,160	728,876	Dec 12 04:17 PM
Linetsky David	Officer	Dec 11 '24	Proposed Sale	24.85	11,853	294,559		Dec 11 05:25 PM
Weintraub Michael	Director	Dec 11 '24	Proposed Sale	25.10	18,574	466,191		Dec 11 04:16 PM
Roberts Evan	Officer	Dec 10 '24	Proposed Sale	24.09	25,000	602,159		Dec 10 04:24 PM
VanDuyn Amy Beth	SVP, Human Resources	Dec 03 '24	Sale	20.93	25,447	532,560	93,470	Dec 05 05:38 PM
Weintraub Michael	Director	Dec 02 '24	Option Exercise	2.03	15,152	30,759	257,979	Dec 04 04:16 PM
Weintraub Michael	Director	Dec 02 '24	Sale	21.01	15,152	318,368	242,827	Dec 04 04:16 PM
VanDuyn Amy Beth	Officer	Dec 03 '24	Proposed Sale	20.93	25,447	532,560		Dec 03 04:48 PM
Weintraub Michael	Director	Dec 02 '24	Proposed Sale	20.77	15,152	314,707		Dec 02 11:52 AM
Linetsky David	SVP, Life Sciences	Oct 18 '24	Sale	20.49	1,100	22,539	200,207	Oct 22 05:51 PM
Linetsky David	Officer	Oct 18 '24	Proposed Sale	20.49	1,100	22,539		Oct 18 01:43 PM
Gandhi Balaji	Chief Financial Officer	Oct 15 '24	Sale	21.03	864	18,166	97,714	Oct 17 04:39 PM
Hoffman Allison C	General Counsel & Secretary	Oct 15 '24	Sale	21.03	1,212	25,482	119,791	Oct 17 04:37 PM
Indig Chaim	Chief Executive Officer	Oct 15 '24	Sale	21.03	3,089	64,947	1,220,647	Oct 17 04:33 PM
Linetsky David	SVP, Life Sciences	Oct 15 '24	Sale	21.03	2,011	42,281	201,307	Oct 17 04:31 PM
Roberts Evan	Chief Operating Officer	Oct 15 '24	Sale	21.03	1,843	38,749	753,876	Oct 17 04:30 PM
VanDuyn Amy Beth	SVP, Human Resources	Oct 15 '24	Sale	21.03	624	13,120	118,917	Oct 17 04:28 PM
Hui Yvonne	Principal Accounting Officer	Oct 15 '24	Sale	20.92	2,791	58,395	27,228	Oct 17 04:27 PM
Hui Yvonne	Principal Accounting Officer	Oct 16 '24	Sale	21.33	423	9,023	26,805	Oct 17 04:27 PM
Hui Yvonne	Officer	Oct 16 '24	Proposed Sale	21.33	423	9,023		Oct 16 11:29 AM
Gandhi Balaji	Officer	Oct 15 '24	Proposed Sale	21.03	864	18,166		Oct 15 05:05 PM
Indig Chaim	Officer	Oct 15 '24	Proposed Sale	21.03	3,089	64,947		Oct 15 04:28 PM
Roberts Evan	Officer	Oct 15 '24	Proposed Sale	21.03	1,843	38,749		Oct 15 04:18 PM
VanDuyn Amy Beth	Officer	Oct 15 '24	Proposed Sale	21.03	624	13,120		Oct 15 04:04 PM
Linetsky David	Officer	Oct 15 '24	Proposed Sale	21.03	2,011	42,281		Oct 15 04:02 PM
Hui Yvonne	Officer	Oct 15 '24	Proposed Sale	21.03	306	6,434		Oct 15 04:01 PM
Hoffman Allison C	Officer	Oct 15 '24	Proposed Sale	21.03	1,212	25,482		Oct 15 03:48 PM
Hui Yvonne	Officer	Oct 15 '24	Proposed Sale	20.91	2,485	51,961		Oct 15 12:00 PM
Linetsky David	SVP, Life Sciences	Sep 19 '24	Sale	24.04	24	577	8,971	Sep 20 04:39 PM
Linetsky David	SVP, Life Sciences	Sep 18 '24	Sale	24.09	61	1,469	8,995	Sep 19 05:49 PM
Linetsky David	SVP, Life Sciences	Sep 17 '24	Sale	24.77	36	892	9,056	Sep 19 05:49 PM
Linetsky David	Member of immediate family of	Sep 19 '24	Proposed Sale	24.04	24	577		Sep 19 04:13 PM
Linetsky David	Member of immediate family of	Sep 18 '24	Proposed Sale	24.09	61	1,469		Sep 18 03:51 PM
Linetsky David	Member of immediate family of	Sep 17 '24	Proposed Sale	24.77	36	892		Sep 17 03:38 PM
Egbuonu-Davis Lisa	Director	Sep 12 '24	Sale	23.03	1,400	32,239	18,139	Sep 13 04:06 PM
Gandhi Balaji	Chief Financial Officer	Sep 10 '24	Sale	23.25	3,502	81,422	98,578	Sep 12 06:03 PM
Hui Yvonne	Principal Accounting Officer	Sep 10 '24	Sale	23.25	744	17,298	30,019	Sep 12 06:02 PM
Indig Chaim	Chief Executive Officer	Sep 10 '24	Sale	23.25	5,295	123,110	1,223,736	Sep 12 06:00 PM
Linetsky David	SVP, Life Sciences	Sep 10 '24	Sale	23.25	1,716	39,897	203,318	Sep 12 05:58 PM
Linetsky David	SVP, Life Sciences	Sep 10 '24	Sale	23.25	95	2,209	9,092	Sep 12 05:58 PM
Roberts Evan	Chief Operating Officer	Sep 10 '24	Sale	23.25	3,148	73,192	755,719	Sep 12 05:55 PM
VanDuyn Amy Beth	SVP, Human Resources	Sep 10 '24	Sale	23.25	737	17,135	119,541	Sep 12 05:53 PM
Hoffman Allison C	General Counsel & Secretary	Sep 10 '24	Sale	23.25	2,622	60,962	123,075	Sep 12 05:51 PM
Hoffman Allison C	General Counsel & Secretary	Sep 11 '24	Sale	23.36	2,072	48,402	121,003	Sep 12 05:51 PM
Egbuonu-Davis Lisa	Director	Sep 12 '24	Proposed Sale	23.03	1,400	32,239		Sep 12 02:04 PM
Hoffman Allison C	Officer	Sep 11 '24	Proposed Sale	23.36	2,072	48,402		Sep 11 09:54 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PHR

Phreesia Inc

Upgrade your FINVIZ experience